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Rationale: Since 2001, antiretroviral therapy (ART) for people living with HIV (PLHIV) has been available in the Lao
People’s Democratic Republic (PDR). A key factor in the effectiveness of ART is good adherence to the prescribed
regimen for both individual well-being and public health. Poor adherence can contribute to the emergence of
drug resistant strains of the virus and transmission during risky behaviors. Increased access to ART in low-income
country settings has contributed to an interest in treatment adherence in resource–poor contexts. This study aims
to investigate the proportion of adherence to ART and identify possible factors related to non-adherence to ART
among people living with HIV (PLHIV) in Lao PDR.
Methods: A cross-sectional study was conducted with adults living with HIV receiving free ART at Setthathirath
hospital in the capital Vientiane and Savannakhet provincial hospitals from June to November 2011. Three hundred
and forty six PLHIV were interviewed using an anonymous questionnaire. The estimation of the adherence rate was
based on the information provided by the PLHIV about the intake of medicine during the previous three days. The
statistical software Epidata 3.1 and Stata 10.1 were used for data analysis. Frequencies and distribution of each
variable were calculated by conventional statistical methods. The chi square test, Mann–Whitney test and logistic
regression were used for bivariate analyses. Multiple logistic regression analysis was conducted to determine the
predictors of non-adherence to ART. A p-value < 0.05 was considered to indicate statistical significance.
Results: Of a total of 346 patients, 60% reported more than 95% adherence to ART. Reasons for not taking
medicine as required were being busy (97.0%), and being forgetful (62.2%). In the multivariate analysis, educational
level at secondary school (OR=3.7, 95% CI:1.3-10.1, p=0.012); illicit drug use (OR=16.1, 95% CI:1.9-128.3, p=0.011);
dislike exercise (OR=0.6, 95% CI:0.4-0.9, p=0.028), and forgetting to take ARV medicine during the last month
(OR=2.3, 95% CI:1.4-3.7, p=0.001) were independently associated with non-adherence.
Conclusions: Non-adherence to ART was associated with individual factors and exposure to ART. Priority measures
to increase adherence to ART should aim to intensify counseling and comprehensive interventions, such as
guidance for PLHIV on medication self-management skills, tailoring the regimen to the PLHIV life style, and
improving adherence monitoring and health care services.
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The introduction of antiretroviral therapy (ART) and
multidrug regimens, or highly active antiretroviral ther-
apy (HAART) has substantially improved the survival of
persons infected with HIV. These drug regimens how-
ever are complex. This, alongside issues of toxicity, side-
effects, disruptions to patient’s daily life and difficulties
in returning for scheduled follow-up consultations, often
makes maintaining adherence over the long term chal-
lenging. Yet the individual and public health benefits of
ART are adherence dependent. Inadequate adherence re-
sults in antiretroviral agents not being maintained at suf-
ficient concentrations to suppress HIV replication in
infected cells to lower the plasma viral load. In addition,
suboptimal adherence can accelerate development of
drug-resistant HIV and mitigate ART’s role in reducing
HIV incidence and transmission. Promoting adherence
is especially important as these treatments become in-
creasingly available and affordable for people living with
HIV (PLHIV) in developing countries where viral load
monitoring is not usually possible [1,2]. Consequently,
more attention is being focused on issues related to
ART adherence.
The importance of ART adherence makes accurate
compliance assessment essential for effective and effi-
cient therapy and evaluation of treatment regimens [3,4].
There are a number of key issues in the study of ART
adherence including having an accurate measure of ad-
herence [5-7]. Measurement of adherence is usually
based on Paterson’s pioneer study found that up to 95%
adherence is necessary for effective HIV viral suppres-
sion [3]. This measurement is usually obtained by using
either a continuous or categorical variable constructed
from patient self-reported adherence that distinguishes
“optimal” from “sub-optimal” adherence based on the
95% threshold [8-10]. A limitation of this method is it
only reflects short-term or average adherence and may
be an over-estimation. Nevertheless, studies have demon-
strated a significant relationship between self-report data
and viral load [8-10].
Besides accurate measurement, other factors of im-
portance in the study of ART adherence include
sassessment of the impact of adherence on viral load
and clinical outcome, identification of the factors that
affect adherence and effective interventions. Under-
standing the factors that affect non-adherence could
provide valuable information about patients most at risk.
Studies suggest that factors associated with adherence
can be grouped under four main categories. One relates
to patient factors, for example demographic characteris-
tics [11]. Another relates to psychological parameter
knowledge, personal skills. A third category relates to
treatment regimen-related factors such as years on treat-
ment, pill burden, side effects; provider-related factorsincluding the patient-provider relationship [12]. The
fourth category relates to environmental and social fac-
tors such as supervision of treatment, HIV-related
stigma and social support [6,13]. While some factors de-
termining non-adherence to ART may be similar across
countries, others may be highly contextual, and culture
or country specific [7,8].
Most ART adherence studies have been undertaken in
high-income countries [5-7]. Few studies have assessed
adherence rates or predictors in low-or lower-middle in-
come countries. This paper presents the findings of a
study which investigated adherence to ART and possible
factors related to non-adherence among PLHIV receiv-
ing ART in two public health facilities in the Lao Peo-
ple’s Democratic Republic (PDR), a lower-middle income
country in South East Asia. As far as the authors are
aware, this is the first such study in Lao PDR. The study
fills a critical gap in understanding ART adherence in
Lao PDR and contributes to the growing adherence re-
search in low-income countries. Such studies are vital to
ensure decisions about adherence interventions are in-
formed by empirical support.
The prevalence of HIV among adults in Lao PDR is
low (0.3%) [14], nevertheless, the number of PLHIV is
increasing. It is estimated that approximately 10,000
people are living with HIV in Lao PDR with the first
case identified in 1990 [1]. The first specific HIV/AIDS
project in Lao PDR was started by Medecins San Fron-
tiers (MSF) in Savannakhet province, in 2001. This pro-
gram offered free service, prophylaxis and treatment for
opportunistic infections (OIs), and ART [15]. Presently,
there are five treatment centers and two satellite sites
providing ART in the country. Two of these centers are
in the capital Vientiane; two are in the southern prov-
inces of Savannakhet and Champasack. The fifth center
is in Luangphabang province in the north. There are also
two satellite sites in the north (Borkeo and Luangnamtha
provinces), also in the north and funded by the Global
Fund to fight AIDS, TB and Malaria (GFATM). While
the program has extended since the first case was identi-
fied, accesses to treatment for PLHIV by the end of
2011, total of 1,988 adults and children PLHIV who
were in need have received ART. This is equivalent to
52.3% of estimated PLHIV eligible for ARV have re-
ceived ART, a small increase compare to 50.8% in 2010
[16]. For 2010 and 2011, despite continuous increase in
the absolute number of PLHIV who received ART, the
percentage rate dropped due to change in calculation for
estimate eligible PLHIV for ART [17].
Methods
Study setting
This study was conducted at the Setthathirath, tertiary
level hospital located in the Vientiane capital and
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areas have the greatest HIV burden and are currently
the two main sites providing free ART and related health
care services. These facilities were selected as they were
the most established clinics providing ART in Lao PDR,
had a pool of HIV-infected patients on ART and were
willing to participate in the study. At the time of the
study in Savannakhet provincial hospital 1,447 HIV pa-
tients were registered of which 1,106 were receiving
ART medicines [18]. In Setthathirath hospital 821 HIV
patients were registered of which 595 were on ART [19].
Study design and participants
This cross-sectional study was performed from January
to March 2011 in Savannakhet and Sethathirath hospi-
tals. Participants in the study were PLHIV receiving free
ART provided by the HIV/AIDS care unit. To be in-
cluded participants had to be 18 years or over and will-
ing to participate in the study. The clinical condition of
the patient had to be suitable for ART based on the CD4
count and to be in the WHO clinical stage for at least
three months. The PLHIV were responsible for how and
when to take the medicine.
Sampling
PLHIV receiving ART were selected consecutively from
both study sites by using probability proportional to size,
based on the number of PLHIV who were on ART. The
participants were selected using simple random sam-
pling. Participants were drawn either from the PLHIV
on ART list at the care unit or during a visit to the HIV/
AIDS care unit for counseling and/or ART medication.
The initial sample size was estimated to be 305 with a
power of 0.84. However, we were able to enroll 346 par-
ticipants, 130 from Sethathirath hospital and 216 from
Savannakhet provincial hospital, 150 were recruited from
the PLHIV on ART list and 196 came for regular visit.
Four respondents declined to be interviewed as part of
the study.
Measurement
Adherence measurement in this study was based on pa-
tient recall of their compliance of the prescribed doses
in the three days prior to the interview. Adherence was
calculated based on the number of pills reported to have
been actually taken divided by the number of prescribed
pills over in the past three days. Patients who reported
an intake of ≥ 95% of the prescribed medication were
considered adherent, those with a reported intake of <
95% were classified as non-adherent.
Data collection
A face-to-face interview with PLHIV by two trained in-
terviewers at the HIV/AIDS center was conducted usinga structured, self-report questionnaire developed by the
Adult AIDS Clinical Trials Group (AACTG) [20] and
slightly modified after a pre-testing at Mahosot hospital,
Vientiane Capital (N=30). The AACTG was developed
based on previous adherence to medical regimen re-
search and has been extensively used to measure ART
adherence. The questionnaire asked patients to recall
their medication intake in terms of their prescribed
doses for the three days prior to the interview. It also
collected demographic data and information about
health behaviors, seriousness of the disease, side effects
and adverse drug reactions. In addition, it asked about
health service-related characteristics of the center pro-
viding ART. Prior to administration, the questionnaire
was translated into Lao and back translated by an inde-
pendent translator. To ensure confidentiality, all respon-
dents were interviewed in a private room at the HIV/
AIDS care unit by the trained interviewers.Data analysis
The statistical software Epi data 3.1 and Stata 10.1 were
used to perform the analysis. The dependent variable
was adherence to ART. To assess factors associated with
non-adherence to ART, univariate, bivariate and multi-
variate analyses were conducted. Univariate analysis used
conventional statistical methods to calculate frequencies
and distribution of each variable. The chi square test
and the Mann–Whitney test as well as a logistic regres-
sion were used for bivariate analyses. Multivariate ana-
lyses were performed to identify factors associated with
premarital sexual activities with only those variables with
p<0.10 from the initial bivariate analyses included in the
model and controlling for other confounders such as
socio-demographic characteristics of the participants
and health risk behaviors (smoking, drinking and doing
exercise). A p-value < 0.05 was considered to indicate
statistical significance.Ethical considerations
The study was undertaken as part of a higher research
degree at KhonKaen University, Thailand. The study
protocol was approved by the Ethic Committee’s
Declaration of the University of Health Sciences, Lao
PDR and the Ethics Committee of the KhonKaen Uni-
versity, Thailand. The interviewer explained the purpose
of the study and procedures and gained written in-
formed consent before commencing the interview. The
participants were also informed that their participation
was voluntary and that they could withdraw from the
interview/discussion at any time without consequences.
The participants were assured that their responses
would be treated in confidence and they were assured
anonymity through the use of strict coding measures.
Table 1 Socio-demographic characteristic of respondents




Age (year) Mean: 36.5±7.6; Min: 20; Max: 66





Primary school 136 39.3
Secondary school 144 41.6
University 34 9.8
Working status
No job 82 23.7
Self employed 195 56.4
Government staff 18 5.2
Private staff 51 14.7
Monthly income (Lao kip) (n=264) Range: 50,000-10,000,000








Duration since HIV diagnosed (months) Mean:46.7±30.1; Min: 3; Max: 168
≤ 36 151 43.6
37-60 90 26.0
>60 105 30.4




Person(s) living in the same house
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Socio-demographics
Three hundred and forty six PLHIV were recruited for
this study. Of these, 47.4% were female with an age
range of 20 to 66 years (Mean ±SD, 36.5±7.6 years).
Slightly higher than two fifths of respondents (41.6%)
were secondary school graduates, just over half (56.4%)
were self employed and received a monthly income
ranging from 50,000 to 10,000,000 kip/month (exchange
rate 1US$=8,000 LAK). Two hundred and twelve
(61.3%) participants were married. Less than half (43.6%)
were HIV positive for less than 36 months. The house-
hold size ranged from 1 to 15 persons (Mean ±SD: 4.7
±2.3 persons). Almost half of the respondents (48.6%)
lived with their spouses or partners and only 10 out of
the 346 respondents lived alone. Almost all of the re-
spondents (93.6%) had disclosed their HIV status to the
people around them (see Table 1).
Health risk behavior characteristics
The health risk behaviors of the respondents included
currently smoking (21.7%), drinking alcohol during the
last month (43.1%), using illicit drugs (3.5%) and having
had multiple sex partners (10.9%). Some gender differ-
ences were observed with most male respondents for ex-
ample, reporting being current smokers while only four
percent of women reported being a current smoker
(p<0.001). Two thirds (60.9%) of men reported drinking
alcohol during the last month, while only twenty percent
of women reported consuming alcohol in the month
prior to the survey (p<0.001). Two thirds (16.5%) of men
reported having multiple sex partners compared to 4.9%
of the women (p=0.001). More women than men how-
ever reported disliking physical exercise (70% vs 37%,
p<0.001). Table 2 shows the reported risk behaviors of
respondents.
Medical history and ART treatment
The number of patients who reported being admitted to
the hospital after being infected with HIV due to poor
health or opportunistic infection was 213(61.6%). The
most common reasons for hospital admission were
prolonged fever, TB/pneumocystis and chronic diarrhea.Table 2 Health risk behaviors by sex of respondents
Behavior Male Female Total P value
Current smoking 68(37.4) 6(3.7) 74(21.5) <0.001
Alcohol drinking (last month ) 111(60.9) 38(23.2) 149(43.1) <0.001
Ever used illicit drug 7(3.9) 5(3.1) 12(3.5) 0.686
Ever had multiple sex partners 30(16.5) 8(4.9) 38(10.9) 0.001
Dislike exercise 67(36.8) 114(69.5) 181(52.3) <0.001Most respondents (91.0%) reported they felt better since
starting ART. Only two patients (0.6%) reported that
their health had become worse after starting ART. Al-
most half 154, (44.5%) of the PLHIV were classified as
being in the clinical HIV stage IV based on the WHO
standard and the CD4 count. The mean CD4 count was
148.1±175.4 mm3 with a range of 2 to 934 with most re-
spondents (88.7%) having CD4 cell counts of less than
350 mm3 which is the threshold to ART treatment
according to the National guidelines [21]. The mean
duration of receiving ART was 38.2 ± 25.9 months, with
44.2% having started ART treatment in the 3 to 30
months prior to the survey. The result of this study
found that the mean of duration of ART started was 38.2
months with a range from 3 to 99 months.Level of non-adherence to ART
Non adherence to the prescribed medication and dosage
was reported by 39.1% PLHIV. The major reasons given
for non-compliance were being too busy and forgetful-
ness (97.0% vs 62.2% respectively). Forty three (12.4%) of
the respondents reported having missed at least one
medical appointment. The reasons for this were given as
being too busy (41.9%), lack of money to travel to the
health center (32.6%) or because the center was too far
from their home (27.9%). One hundred and eighty one
(52.3%) patients reported having had experienced side-
effects due to their treatment. Of these, the most com-
mon symptom was a rash (42%), followed by headache
or dizziness (34.3%) and numbness (32.6%) (see Table 3).
In order to examine factors associated with adherence,
two groups were created. One consisted of those with an
adherence score of ≥ 95% (n=206, 59.5%). Participants
with adherence scores of ≤ 95% (n=140, 40.5%) were al-
located to a non-adherence group.Factors associated with ART adherence
The results of the bivariate analysis (Table 4) revealed a
statistically significant association with non-adherence
in the 36 to 45 age group compared to those who
were ≤ 35 years or who were more than 46 years old
(p=0.019). Being a graduate of a secondary school was
also observed to have a statistically significant association
with non-adherence (p=0.008). Patients who had been
diagnosed HIV positive for more than 60 months
reported statistically significantly better adherence than
those who became aware of their HIV infection in the 36
to 45 months (p=0.045) prior to the survey. Use of illegal
drug substances was found to be statistically significantly
associated with non-adherence (p=0.006), disliking exer-
cise (p=0.025) or having forgotten to take ART medicine
during last month (p=0.001).
Table 3 Medical history and ART of respondents
Medical history and ART treatment Number (n=346) Percentage (%)
Admitted to the hospital related to HIV infection
No 133 38.4
Yes 213 61.6
Reasons for hospital admittance (n=213)
Chronic diarrhea 77 36.2
Chronic herpes simplex infection 10 4.7
TB/pneumocystis 91 42.7
Meningitis 24 11.3
Prolong fever 100 46.9
Weight loss 66 30.9
Jaundice 14 6.6
WHO clinical stage
Stage I 22 6.4
Stage II 45 13.0
Stage III 125 36.1
Stage IV 154 44.5
CD4 at initiation of ART (n=326) Mean148.1±175.4; Min: 2; Max: 934
< 350/mm3 289 88.7
≥350/mm3 37 11.3




Number of ARV medicines received
1 67 19.4
≥2 279 80.6




Ever forgotten to take ARV medicine in the last month
Never 211 60.9
Ever 135 39.1
Reasons for forgetting to take ARV medicine (n=135)
Forgot 84 62.2
Busy 131 97.0
Too many pills/taste of medicine 5 3.7
Long distance to hospital 10 7.4
Run out of medicine 7 5.2
Severe symptoms/difficult to follow-up 6 4.4
Stigma 7 5.2
Ever had side effects of ARV medicine
Never 165 47.7
Ever 181 52.3
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Table 3 Medical history and ART of respondents (Continued)
Ever missed an appointment
Never 303 87.6
Ever 43 12.4
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associated with non-adherence to ART
After adjustment for established risk factors for non-
adherence (Table 4), factors that remained significantly
associated with non-adherence were education attain-
ment at secondary school (OR= 3.7; 95% CI: 1.3-10.1,
p = 0.012), illicit drug use (OR = 16.1; 95% CI: 1.9-128.3,
p = 0.011), disliking exercise (OR = 0.6; 95% CI:0.4-0.9,
p = 0.028), and forgetting to take ART medicine during
the last month (OR=2.3; 95% CI:1.4-3.7, p = 0.001).
Discussion
In this study, we examined factors associated with ART
adherence in Lao PDR. Non-adherence usually meansTable 4 Factor associate with antiretroviral therapy (ART) adh
Characteristic Adherence in pa
≥95% (n=206)
Age (years)





Primary school 86 (63.2)
Secondary school 74 (51.4)
University 21 (61.8)
Duration since HIV diagnosis (month)
≤ 36 98 (64.9)
37-60 53 (58.9)
>60 55 (52.4)











Yes 20 (41.5)skipping one dose of medicine. Based on the self-report
questionnaire, the study results indicated that more than
half of the PLHIV had good adherence to ART defined
as ≥95%. Nevertheless, 40% of respondents reported
poor ART adherence. This is a concern given poor ad-
herence severely compromises effectiveness and is linked
with the likelihood of the drug resistance. Non-
adherence to ART in this study was associated with
socio-demographic characteristics, illicit drug use, and
history of taking ART. In the final model in our sample,
the variables educational level at secondary school, hav-
ing used illicit drugs, having started ART within the last
31–60 months and forgetfulness played a significant role
in predicting adherence to ART.erence with in the past 3 days (n=346)
st 3 days (%) *Odds ratio (95% confidence interval)
<95% (n=140) Unadjusted p Adjusted p
58 (34.9) 1
67 (48.2) 1.7(1.1-2.7) 0.019 - -
15 (36.6) 1.1(0.5-2.2) 0.834 - -
7 (21.9) 1
50 (36.8) 2.1(0.8-5.1) 0.115 - -
70 (48.6) 3.4(1.4-8.3) 0.008 3.7(1.3-10.1) 0.012
13 (38.2) 2.2(0.7-6.5) 0.152 - -
53 (35.1) 1
37 (41.1) 1.2(0.8-2.2) 0.315 - -
50 (47.6) 1.7(1.1-2.8) 0.045 - -
129 (46.7) 1
11 (34.8) 17.5(2.2-137.0) 0.006 16.1(1.9-128.3) 0.011
77 (40.5) 1
63 (34.8) 0.6(0.4-0.9) 0.025 0.6(0.4-0.9) 0.028
70 (33.2) 1
70 (51.8) 2.2(1.4-3.4) 0.001 2.3(1.4-3.7) 0.001
117 (38.6) 1 - -
23 (53.5) 1.8(0.9-3.5) 0.066 - -
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our study is similar to that found in a study in Zambia
and one in India [22,23], but lower than studies China
[24], and Vietnam [25]. It is also lower than reported in
studies conducted in developed countries using similar
self-report measures [26,27]. Some caution is needed in
comparing adherence rates across studies however, as
the methods of measuring adherence (self-report vs. pill
counts or medication electronic monitoring system
(MEMS) and settings such as free ART vs. non-free,
rural vs. urban, plasma donor vs. injecting drug users or
other risk groups) can affect findings. Measurement of
ART adherence is also problematic as patients may over-
estimate their adherence due to recall bias, the demand
characteristics of patient-provider consultation and the
desire to avoid criticism [27].
In our study, reasons given for non-adherence related
to being busy, forgetfulness and distance to the clinic.
Other reasons given included running out of medication,
having too many pills to take, the taste of the medica-
tion, severe side effects, difficulties in maintaining the
medication regiment and self-stigma. Self-stigma may
lead to patients being unwilling or fearful of taking
medicine when other people are present [24]. A qualita-
tive study in Vietnam identified self-stigma as a perva-
sive barrier to ART adherence with patients concerned
that taking medications in the presence of others could
lead to unplanned disclosure of their HIV status [28].
Forgetfulness was identified in our study as a significant
variable in predicting adherence to ART. This is similar
to a study in rural China [24]. In the present study, we
found a statistically significant association between non-
adherence and secondary school educational level. Other
studies have shown low levels of education as an import-
ant factor associated with non-adherence and a general
barrier for medical care [29,30]. In contrast, a study in
Bangalore, India found education had no effect on ad-
herence [31]. This difference in findings may be due to
our participant group in general being relatively well ed-
ucated and thus more aware about the problems of sub-
optimal treatment.
Illicit drug use has been associated with depression
and anxiety, either as part of the withdrawal process or
because of repeated use. This is particularly relevant in
the treatment of HIV infection because depression is
one of the strongest predictors of poor adherence and
poor treatment outcomes [30]. Our study found that
illicit drug use was a contributing factor to non-
adherence based on the 95% threshold. Illicit drug use
has been reported to reduce the level of adherence in
many studies [32-34]. Various studies have documented
that widespread illicit drug use among PLHIV makes
their treatment complicated and hinders their quality of
life [4,35]. It has also been suggested that less than 95%adherence when combined with illicit drug may lead to
viral suppression [3].
Being on ART for 31–60 months was significantly as-
sociated with non-adherence to ART in this study. This
finding is supported by Andreo C. et al. who found that
where patients had been on ART medication for more
than two years, increased non-adherence was observed
[36]. This could be because the longer patients are on
treatment they become complacent and find it harder to
follow the strict regimen. Research in Vietnam also iden-
tified that over time, family members who had initially
played a supportive role in helping patients take their
medication, assumed the PLHIV was taking their medi-
cation as prescribed and followed up with the patient
less regularly [28]. This factor may also be a contributing
factor in decreased adherence over time.
Some studies have identified side effects of ART medi-
cations as significant barriers to good adherence [37]. In
this study, although half of the patients (52.3%) reported
signs and symptoms of adverse reactions to their treat-
ment, further analysis did not identify these factors as
being significantly related to non-adherence. However,
this might be due to the limitations of the methods used
as both non-adherence and the adherence group
reported having trouble with side effects. Nevertheless, it
would seem to be a priority that ART programs should
where possible, increase the availability of regimens with
fewer adverse reactions.
In the present study, no difference in adherence levels
based on the duration of taking ART and WHO clinical
stages was observed. In addition, the CD4 count at the
start of treatment did not significantly correlate with
non-adherence to ART. A study in India demonstrated
an association between self-reported adherence and im-
provement in CD4 counts [31]. According to Sarna
et al., [38] lower improvement in CD4 counts during the
early stages of taking ART medication may be due to a
delay between virologic and immunologic failure.
The present study suggests that to increase ART com-
pliance a number of strategies are required. There has
been limited research however on the effectiveness of
strategies to enhance adherence in low-income settings.
Directly observed therapy (DOT) as used in tuberculosis
treatment, has been used with ART with some effect but
is resource intensive [39]. In Vietnam, perceptions of
stigma prevented home-based DOT being viewed as ac-
ceptable [28]. Other interventions include limiting the
size, number, side effects and frequency of pills taken
per day. Such regimens are likely to be more attractive
to patients trying to conceal their HIV status for fear of
stigma [28].
Mobile phones can provide an inexpensive and con-
venient means of communication to support treatment
compliance. Randomized controlled trials have found
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in in low-resource settings [40]. A trial in Kenya for ex-
ample found a weekly mobile phone text asking in the
local language “how are you?” improved viral suppres-
sion outcomes when compared with care [41]. In focus
group interviews patients reported that the weekly mes-
sages made them feel that someone cared. Another trial
found that short weekly one-way text messaging im-
proved medication adherence whereas daily messaging
did not [42]. A study in Vietnam however, found that
while there was overall acceptance of the use of mobile
phones, stigma and fear of HIV disclosure were a barrier
to use [25]. In Lao PDR, mobile phones are sometimes
used to contact the patients when they miss appoint-
ments but texting or other mobile phone functions are
not currently used to encourage compliance. Given in
the present study stigma was a barrier to optimal ART
compliance and some HIV patients were also illegal
drug-users, further research into the appropriateness of
mobile phone use as a form of adherence support in Lao
PDR is needed. Issues of confidentiality would also need
to be addressed. Research would also be needed to iden-
tify the preferred types of mobile phone functions for
adherence maintenance. Provider attention to develop-
ing a good relationship with the patient, taking time to
address concerns about the medications and side-effects
can improve adherence. Counseling, education and peer
support are other interventions which have been identi-
fied as being effective [25]. In Vietnam a randomized
controlled trial found peer support improved quality of
life and adherence after 12 months among ART patients
presenting at clinical stages 3 and 4 at baseline, but had
no impact on quality of life among ART patients en-
rolled at clinical stages 1 and 2 [28].
Limitations of study
The findings of this study must be interpreted in the
light of its limitations. The study was conducted at only
two sites in the country and the findings may not be
generalizable to other clinical settings. There is no gold
standard for measuring adherence and our measurement
of adherence is based on PLHIV self-reports of missed
doses which may be subject to social desirability and re-
call biases. The literature for example, suggests that
PLHIV tend to overestimate adherence [43]. However,
many other studies document that well collected self-
reported data clearly correlate with virologic change and
is more practical in most settings [44]. A meta-analysis
of several studies demonstrated a good correlation be-
tween self-reported medication adherence and virologic
outcomes and that self-reported lower non-adherence to
be more reliable than self-reported higher adherence
[45,46]. Further, in the present study, adherence infor-
mation was collected by the non-clinical research staffso there was less reason for participants to over-report
adherence. We were also unable to relate the obtained
adherence rate to CD4 cell count due to financial and lo-
gistical barriers to frequent laboratory monitoring, a
limitation common in low and low-middle income
countries.
It is also possible that selection bias occurred, as only
those PLHIV who were on ART at the time of data col-
lection were included, whereas those who were lost-to
-follow up or could not attend the clinic to collect medi-
cation were excluded. The cross-sectional design of this
study means we could only estimate levels of adherence
at one point in time while adherence to medication is a
dynamic process and participants’ behavior may change
over time. In addition, the design means that casual rela-
tionships between ART non-adherence and other corre-
lates cannot be identified and we can only demonstrate
association between levels of education, illicit drug use,
duration since the initiation of ART and non-adherence.
Additionally, we collected PLHIV consecutively attend-
ing the care units over a limited time. Finally, the focus
of this research was on individual patient factors affect-
ing adherence. Additional research is needed to better
understand heath care provider and health care system
determinants of treatment adherence.Conclusions
The high level of non-adherence to ART found in this
study (40%) is a public health concern. In view of the
serious implications of non-adherence for public health,
there is a critical need for targeted intervention
strategies that increase the level of adherence. Non-
adherence to ART in this study was associated with
socio-demographic characteristics, illicit drug use, and
history of taking ART. The findings of this study suggest
there is a need increase the strategies used to promote
adherence. It is likely that a range of interventions is
needed, including increasing education, counseling,
guidance on medication self-management skills and tai-
loring the regimen to PLHIV life styles. The feasibility of
low–cost technologies such as mobile phones should
also be explored. Improving adherence health care mon-
itoring including guidelines for health care workers on
monitoring adherence and strengthening peer and family
support can also be effective strategies. Qualitative re-
search is also required to understand contextual factors
in identifying the optimal mix of support interventions
and for who. Evaluation is also required of any interven-
tions aimed at increasing ART to better understand cost
effective measures in low-income settings.Competing interests
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